Role of Cholesterol in Alzheimer's Disease Unclear

Key points
- It sounds simple: The lower your cholesterol, the better your heart health.
- There are two major forms of dementia: vascular dementia and Alzheimer's disease.
- The connection between Alzheimer’s disease and cholesterol is even more complex.
- The urgent question is whether cholesterol-lowering drugs, such as statins, can reduce the risk of Alzheimer’s disease.
It sounds simple: The lower your cholesterol, the better your heart health. But a man's heart and his head don't always agree. In fact, the relationships among cholesterol levels, psychological function, and neurologic disorders are complex and sometimes controversial, reports the March 2007 issue of Harvard Men’s Health Watch.
There are two major forms of dementia: vascular dementia and Alzheimer's disease. Vascular dementia results when blood vessel damage deprives the brain of oxygen. Brain cells die as a result, and mental function suffers. Some studies link high cholesterol levels to an increased risk of cognitive impairment, but others report the opposite. More research is needed to sort this out, but even now, investigations of HDL (good) cholesterol and mental function have consistently reported that high HDL levels appear to help preserve mental function in older people.
The connection between Alzheimer’s disease and cholesterol is even more complex. Scientists have learned much of the damage of Alzheimer’s comes from deposits of a sticky protein, called beta-amyloid, in vital areas of the brain. In some studies, high cholesterol levels appear to accelerate the formation of beta-amyloid plaques. People with the genetic trait that increases the level of a particular cholesterol transport protein have a greatly increased risk of late-onset Alzheimer’s.
The urgent question is whether cholesterol-lowering drugs, such as statins, can reduce the risk of Alzheimer’s disease. In the most recent studies, people who took statins did not appear to be at lower risk for the disease. Additional research is under way. Right now, it is too early for firm conclusions on the relationships among cholesterol, cognitive function, and statin therapy.
Also in this issue:
• Selenium and prostate cancer
• Does pre-hypertension matter?
• A doctor discusses: Exercise and free radicals
Harvard Men’s Health Watch is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $24 per year. Subscribe at www.health.harvard.edu/men or by calling 1-877-649-9457 (toll free).
Source: Harvard Men's Health Watch
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsRaising "good" cholesterol cuts heart disease risk
Increasing the level of HDL ("good") cholesterol by itself is enough to reduce cardiovascular risk in certain people, according to a report from Scotland. Researchers found "evidence of an independent benefit of raising…
10 June 2006
NewsRare Form of Alzheimer's Disease Found in Camelford Resident
A rare form of Alzheimer's disease has been discovered in a resident of Camelford, the town in south west England which bore the brunt of the accidental discharge of 20 tonnes of aluminium sulphate into the local water…
21 April 2006
NewsStatins may be able to play a role in preventing or slowing heart valve disease
Research to be published in the April 18 issue of the Journal of the American College of Cardiology provides the first explanation of an active rather than passive process that leads to heart valve degeneration,…




